血管酶转化酶在与心血管疾病免疫相关的病原发生中的作用
Xinyi Li1, Huasheng Ding2, Gaoke Feng1
1Department of Cardiology and Cardiovascular Research Institute, Renmin Hospital of Wuhan University, Wuhan, Hubei, China; Hubei Key Laboratory of Cardiology, Wuhan, Hubei, China.
Life sciences
|July 10, 2024
概括
ангиотензин转化酶 (ACE) 通过调解免疫反应,在心血管疾病 (CVD) 中发挥关键作用. ACE 抑制剂可能为管理心血管疾病和COVID-19相关心血管并发症提供新的治疗策略.
科学领域:
- 免疫学 免疫学 免疫学
- 心脏病学 心脏病学
- 药理学 药理学是指药理学的学科.
背景情况:
- 氨酸- ангиотензин系统 (RAS) 的组成部分,氨酸转化酶 (ACE),与免疫反应有关.
- 慢性心血管疾病 (CVD) 与失调的免疫反应有关,特别是来自髓状细胞和淋巴细胞的免疫反应.
- 用于高血压的ACE抑制剂 (ACEi) 具有潜在的抗炎作用.
研究的目的:
- 研究ACE及其相关物质及其信号通路在心血管疾病免疫病原发生过程中的作用.
- 探索ACE抑制在心血管疾病和COVID-19相关心血管损伤中的潜在益处.
主要方法:
- 关于ACE,免疫反应和心血管疾病的现有文献的审查.
- 分析ACE抑制对免疫细胞活性和炎症标记物的影响.
- 检查ACE在COVID-19引起的心血管损伤中的作用.
主要成果:
- ACE是免疫细胞动员,新陈代谢和免疫调节分子生产的重要媒介.
- 在心血管疾病发病过程中,不受控制的免疫反应与ACE活性有关.
- 由于其在免疫过度激活中的作用,ACE可能导致COVID-19中的心血管损伤.
结论:
- ACE及其通路在动脉高血压,动脉样硬化和心律失常的免疫相关病原发生中至关重要.
- 抑制ACE是一种有前途的治疗途径,用于心血管疾病管理.
- 针对ACE可以减轻在COVID-19等条件下免疫介导的心血管损伤.
相关概念视频
01:30Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
600
Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
600
01:30Antihypertensive Drugs: Angiotensin II Receptor Blockers
695
In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
695
01:25Antihypertensive Drugs: Direct Renin Inhibitors
546
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
546
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
419
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
419
01:17Hormonal Regulation of Blood Pressure
2.6K
Endocrinal or hormonal intervention in the cardiovascular system is predominantly exerted by the catecholamines - epinephrine and norepinephrine, as well as a slew of hormones that interact with renal function to modulate blood volume.
Epinephrine and Norepinephrine
The adrenal medulla releases epinephrine and norepinephrine, catecholamines that enhance and extend the sympathetic or "fight or flight" physiological response. These hormones escalate heart rate and the force of contraction...
Epinephrine and Norepinephrine
The adrenal medulla releases epinephrine and norepinephrine, catecholamines that enhance and extend the sympathetic or "fight or flight" physiological response. These hormones escalate heart rate and the force of contraction...
2.6K
01:18Hypertension and Regulation of Blood Pressure
2.0K
Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
2.0K